Literature DB >> 29933823

Nontraditional Alcohol and Opioid Agonist Treatment Interventions.

Christopher Fairgrieve1, Nadia Fairbairn2, Jeffrey H Samet3, Seonaid Nolan4.   

Abstract

Despite the availability of effective medications and psychosocial interventions for the management of a substance use disorder, some individuals repeatedly fail the most aggressive treatment regimens. For such individuals, alternative treatment options exist seeking to mitigate the negative consequences of the use of harmful substances. Participation in a managed alcohol program, or the use of sustained-release oral morphine or injectable opioid agonist treatment or the creation of safe injecting facilities, are examples of such nonstandard approaches. This article reviews the available evidence of these treatment modalities.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Injectable opioids; Managed alcohol; Severe alcohol use disorder; Severe opioid use disorder; Sustained release oral morphine

Mesh:

Substances:

Year:  2018        PMID: 29933823      PMCID: PMC6650149          DOI: 10.1016/j.mcna.2018.02.006

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  3 in total

1.  Association between posttraumatic stress disorder and nonfatal drug overdose.

Authors:  William K Lee; Kanna Hayashi; Kora DeBeck; M J S Milloy; Cameron Grant; Evan Wood; Thomas Kerr
Journal:  Psychol Trauma       Date:  2019-09-16

Review 2.  Stimulant safe supply: a potential opportunity to respond to the overdose epidemic.

Authors:  Taylor Fleming; Allison Barker; Andrew Ivsins; Sheila Vakharia; Ryan McNeil
Journal:  Harm Reduct J       Date:  2020-01-10

3.  Exploring the experience of inpatients with severe alcohol use disorder on a managed alcohol program (MAP) at St. Paul's Hospital.

Authors:  Beena P Parappilly; Emma Garrod; Ryan Longoz; Eric Eligh; Holly van Heukelom; Christopher Kit Fairgrieve; Bernadette Pauly
Journal:  Harm Reduct J       Date:  2020-05-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.